Prevalence and incidence of heart failure among community in China during a three-year follow-up

Lu FU; Jun-Rong JIANG; Wei-Dong LIN; Hui-Yi LIU; Shu-Yu JIN; Xing-Dong YE; Yan-Lin CHEN; Si-Jia PU; Yang LIU; Shang-Fei HE; Shu-Lin WU; Hai DENG; Yu-Mei XUE

doi:10.26599/1671-5411.2023.04.008

Volume 20 Issue 4

Apr. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Geriatric Cardiology > 2023 > 20(4): 284-292

Please cite this article as: FU L, JIANG JR, LIN WD, LIU HY, JIN SY, YE XD, CHEN YL, PU SJ, LIU Y, HE SF, WU SL, DENG H, XUE YM. Prevalence and incidence of heart failure among community in China during a three-year follow-up. J Geriatr Cardiol 2023; 20(4): 284−292. DOI: 10.26599/1671-5411.2023.04.008

Citation:

Please cite this article as: FU L, JIANG JR, LIN WD, LIU HY, JIN SY, YE XD, CHEN YL, PU SJ, LIU Y, HE SF, WU SL, DENG H, XUE YM. Prevalence and incidence of heart failure among community in China during a three-year follow-up. J Geriatr Cardiol 2023; 20(4): 284−292. DOI: 10.26599/1671-5411.2023.04.008

Citation:

PDF( 2923 KB)

Prevalence and incidence of heart failure among community in China during a three-year follow-up

doi: 10.26599/1671-5411.2023.04.008

Lu FU¹,
Jun-Rong JIANG¹,
Wei-Dong LIN¹,
Hui-Yi LIU¹,
Shu-Yu JIN^{1, 2},
Xing-Dong YE¹,
Yan-Lin CHEN¹,
Si-Jia PU^{1, 3},
Yang LIU¹,
Shang-Fei HE⁴,
Shu-Lin WU^{1, 5},
Hai DENG^{1, 6
,
,},
Yu-Mei XUE^{1, 5
,
,}

1.
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
2.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
3.
School of Medicine, South China University of Technology, Guangzhou, China
4.
Department of Cardiology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
5.
Guangdong Provincial Key Laboratory of Clinical Pharmacology, Research Center of Medical Sciences, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
6.
Qinghai Province Cardio Cerebrovascular Disease Specialist Hospital, Xining, China

More Information

Corresponding author: doctordh@hotmail.com (DENG H); xymgdci@163.com (XUE YM)
Publish Date: 2023-04-28

Abstract

Abstract

BACKGROUND Epidemiological surveys on heart failure (HF) in Chinese community are relatively lacking. This study aimed to estimate the prevalence and incidence of HF among community residents in southern China. METHODS Baseline data of this prospective study was collected from 2015 to 2017 among 12,013 permanent residents aged ≥ 35 years in Guangzhou, China. The same survey process was carried out for individuals aged ≥ 65 years after a three-year follow-up. RESULTS The overall prevalence of HF in community residents aged ≥ 35 years was 1.06%. Male had significantly higher risk of HF prevalence [odds ratio (OR) = 1.50, P = 0.027]. The gender-adjusted risk of HF was 1.48 times higher per 10 years aging. HF prevalence was statistically associated with atrial fibrillation, valvular heart disease, hypertension and chronic obstructive pulmonary disease after adjusting for age and gender (OR = 8.30, 5.17, 1.11, 2.28, respectively; all P < 0.05). HF incidence in individuals aged ≥ 65 years were 847 per 100,000 person-years. Baseline atrial fibrillation, valvular heart disease, and diabetes mellitus were risk factors for HF incidence for individuals aged ≥ 65 years adjusting for age and gender (OR = 5.05, 3.99, 2.11, respectively; all P < 0.05). Besides, residents with new-onset atrial fibrillation and myocardial infarction were at significantly higher risk of progression to HF (OR = 14.41, 8.54, respectively; all P < 0.05). CONCLUSIONS Both pre-existing and new-onset cardiovascular diseases were associated with HF incidence in southern China. Management of related cardiovascular diseases may be helpful to reduce the incidence of HF.

FullText(HTML)

References(30)

References

[1]	Tomasoni D, Adamo M, Lombardi CM, et al. Highlights in heart failure. ESC Heart Fail 2019; 6: 1105−1127. doi: 10.1002/ehf2.12555
[2]	Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163−2196. doi: 10.1016/S0140-6736(12)61729-2
[3]	Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail 2021; 14: e008406. doi: 10.1161/CIRCHEARTFAILURE.121.008406
[4]	Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137−1146. doi: 10.1136/hrt.2003.025270
[5]	Gu DF, Huang GY, He J, et al. [Investigation of prevalence and distributing feature of chronic heart failure in Chinease adult population]. Zhonghua Xin Xue Guan Bing Za Zhi 2003; 31: 3−6. [In Chinese].
[6]	Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail 2019; 21: 1329−1337. doi: 10.1002/ejhf.1629
[7]	Deng H, Guo P, Zheng M, et al. Epidemiological characteristics of atrial fibrillation in southern China: results from the Guangzhou Heart Study. Sci Rep 2018; 8: 17829. doi: 10.1038/s41598-018-35928-w
[8]	Fu L, Deng H, Lin WD, et al. Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou Heart Study. BMC Cardiovasc Disord 2019; 19: 270. doi: 10.1186/s12872-019-1253-6
[9]	Lin WD, Deng H, Guo P, et al. High prevalence of hyperuricaemia and its impact on non-valvular atrial fibrillation: the cross-sectional Guangzhou (China) Heart Study. BMJ Open 2019; 9: e028007. doi: 10.1136/bmjopen-2018-028007
[10]	Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194−202. doi: 10.1001/jama.289.2.194
[11]	Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular aging and heart failure: JACC review topic of the week. J Am Coll Cardiol 2019; 74: 804−813. doi: 10.1016/j.jacc.2019.06.053
[12]	Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart Fail 2020; 8: 523−536. doi: 10.1016/j.jchf.2020.01.014
[13]	Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72: S3−S9. doi: 10.1136/hrt.72.2_suppl.s3
[14]	Webb CL, Jenkins KJ, Karpawich PP, et al. Collaborative care for adults with congenital heart disease. Circulation 2002; 105: 2318−2323. doi: 10.1161/01.CIR.0000017557.24261.A7
[15]	Goldberg RJ, Spencer FA, Farmer C, et al. Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med 2005; 118: 728−734. doi: 10.1016/j.amjmed.2005.04.013
[16]	Crespo-Leiro MG, Barge-Caballero E. Advanced heart failure: definition, epidemiology, and clinical course. Heart Fail Clin 2021; 17: 533−545. doi: 10.1016/j.hfc.2021.06.002
[17]	Yang Y, Wang Z, Chen Z, et al. Current status and etiology of valvular heart disease in China: a population-based survey. BMC Cardiovasc Disord 2021; 21: 339. doi: 10.1186/s12872-021-02154-8
[18]	Liu FZ, Xue YM, Liao HT, et al. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of southern China. J Thorac Dis 2014; 6: 1724−1730. doi: 10.3978/j.issn.2072-1439.2014.11.21
[19]	Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147−e239. doi: 10.1016/j.jacc.2013.05.019
[20]	Senni M, Iorio A, Seferović P. Heart failure with preserved ejection fraction in Asia: the far side of the moon? Eur J Heart Fail 2019; 21: 37−39. doi: 10.1002/ejhf.1335
[21]	Tromp J, Teng TH, Tay WT, et al. Heart failure with preserved ejection fraction in Asia. Eur J Heart Fail 2019; 21: 23−36. doi: 10.1002/ejhf.1227
[22]	Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry. J Card Fail 2017; 23: 868−875. doi: 10.1016/j.cardfail.2017.09.014
[23]	Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011; 8: 30−41. doi: 10.1038/nrcardio.2010.165
[24]	Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 2018; 391: 572−580. doi: 10.1016/S0140-6736(17)32520-5
[25]	Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397−1402. doi: 10.1056/NEJMoa020265
[26]	Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344−350. doi: 10.1001/jama.292.3.344
[27]	Tseng CH. The age- and sex-specific incidence and medical expenses of heart failure hospitalization in 2005 in Taiwan: a study using data from the National Health Insurance. J Am Geriatr Soc 2010; 58: 611−613. doi: 10.1111/j.1532-5415.2010.02755.x
[28]	Hung YT, Cheung NT, Ip S, et al. Epidemiology of heart failure in Hong Kong, 1997. Hong Kong Med J 2000; 6: 159−162.
[29]	Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC international. J Am Coll Cardiol 2019; 73: 3135−3147. doi: 10.1016/j.jacc.2019.04.036
[30]	Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol 2019; 16: 203−212. doi: 10.1038/s41569-018-0119-4